These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28551045)

  • 1. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
    Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
    Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue is associated with poor outcomes in vasoplegic shock.
    Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study.
    Mazzeffi M; Hammer B; Chen E; Caridi-Scheible M; Ramsay J; Paciullo C
    Ann Card Anaesth; 2017; 20(2):178-181. PubMed ID: 28393777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
    Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
    Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative vasoplegia: methylene blue to the rescue!
    McCartney SL; Duce L; Ghadimi K
    Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
    Peyko V; Finamore M
    Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
    Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
    Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
    Carley M; Schaff J; Lai T; Poppers J
    A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
    Petermichl W; Gruber M; Schoeller I; Allouch K; Graf BM; Zausig YA
    J Cardiothorac Surg; 2021 Jul; 16(1):205. PubMed ID: 34321019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.
    Evora PR; Alves Junior L; Ferreira CA; Menardi AC; Bassetto S; Rodrigues AJ; Scorzoni Filho A; Vicente WV
    Rev Bras Cir Cardiovasc; 2015; 30(1):84-92. PubMed ID: 25859872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
    Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
    Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.
    Cai Y; Mack A; Ladlie BL; Martin AK
    Ann Card Anaesth; 2017; 20(4):462-464. PubMed ID: 28994688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
    Gilbert M; Lema G
    Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.
    Perdhana F; Kloping NA; Witarto AP; Nugraha D; Yogiswara N; Luke K; Kloping YP; Rehatta NM
    Asian Cardiovasc Thorac Ann; 2021 Oct; 29(8):717-728. PubMed ID: 33653154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
    Evora PR; Ribeiro PJ; Vicente WV; Reis CL; Rodrigues AJ; Menardi AC; Alves Junior L; Evora PM; Bassetto S
    Rev Bras Cir Cardiovasc; 2009; 24(3):279-88. PubMed ID: 20011872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.